{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T19:13:38Z","timestamp":1718824418984},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2008,5,5]],"date-time":"2008-05-05T00:00:00Z","timestamp":1209945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Surrogate marker(s) of protection in human leishmaniasis is not well defined. In this study, T helper 1 (Th1) and Th2 cytokine profiles and CD26 expression on CD4+ T cells in peripheral blood mononuclear cells of patients with healing or non-healing forms of cutaneous leishmaniasis (CL) stimulated with Leishmania antigens were assessed. The level of interferon (IFN)-\u03b3 production was significantly higher in patients with healing or non-healing forms of CL than in healthy controls, but it was not significantly different between the two patient groups. The level of interleukin-5 production was significantly higher in patients with the non-healing form of CL than in the two other groups. There was a significant increase in the level of CD26 expression on CD4+ T cells in patients with healing (P\u2003&amp;lt;\u20030\u00b7001) or non-healing (P\u2003=\u20030\u00b7025) forms of CL compared with the control group, but no significant difference was seen between the two patient groups. A weak positive correlation was seen between IFN-\u03b3 production and CD26 expression on CD4+ T cells of patients with the healing form of lesion (r\u2003=\u20030\u00b754, P\u2003=\u20030\u00b7008), but this correlation was not observed in patients with the non-healing form of CL (r\u2003=\u20030\u00b753, P\u2003=\u20030\u00b7078). Surface CD26 is not correlated with the clinical manifestation of CL or IFN-\u03b3 production. Therefore, CD26 is not a surrogate marker for IFN-\u03b3 production in CL.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2008.03666.x","type":"journal-article","created":{"date-parts":[[2008,10,13]],"date-time":"2008-10-13T00:03:05Z","timestamp":1223856185000},"page":"31-36","source":"Crossref","is-referenced-by-count":8,"title":["CD26 expression on CD4+ T cells in patients with cutaneous leishmaniasis"],"prefix":"10.1093","volume":"153","author":[{"given":"R","family":"Jafari-Shakib","sequence":"first","affiliation":[{"name":"Department of Immunology, School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Ajdary","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z Mohtasham","family":"Amiri","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, School of Medicine, Guilan University of Medical Science, Rasht, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A M","family":"Mohammadi","sequence":"additional","affiliation":[{"name":"Center for Research and Training in Skin Diseases and Leprosy (CRTSDL)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Nourijelyani","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Mortazavi","sequence":"additional","affiliation":[{"name":"Razi Hospital, School of Medicine, University of Tehran\/Medical Sciences (TUMS)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M A","family":"Shokrgozar","sequence":"additional","affiliation":[{"name":"National Cell Bank of Iran, Pasteur Institute, Tehran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Nikbin","sequence":"additional","affiliation":[{"name":"Department of Immunology, School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Khamesipour","sequence":"additional","affiliation":[{"name":"Center for Research and Training in Skin Diseases and Leprosy (CRTSDL)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,5,5]]},"reference":[{"key":"2022010405125948200_b1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0738-081X(99)00047-4","article-title":"Cutaneous leishmaniasis: clinical features and diagnosis","volume":"17","author":"Salman","year":"1999","journal-title":"Clin Dermatol"},{"key":"2022010405125948200_b2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0035-9203(97)90275-3","article-title":"Dermotropic isolates of Leishmania infantum in Iran","volume":"91","author":"Hatam","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2022010405125948200_b3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0738-081X(96)00058-2","article-title":"Cutaneous leishmaniasis","volume":"14","author":"Dowlati","year":"1996","journal-title":"Clinical Aspect Clin Dermatol"},{"key":"2022010405125948200_b4","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J Immunol"},{"key":"2022010405125948200_b5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2002.tb11101.x","article-title":"Type 1 and type 2 responses to Leishmania major","volume":"209","author":"Rogers","year":"2002","journal-title":"FEMS Microbiol Lett"},{"key":"2022010405125948200_b6","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1128\/IAI.68.4.1760-1764.2000","article-title":"Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection","volume":"68","author":"Ajdary","year":"2000","journal-title":"Infect Immun"},{"key":"2022010405125948200_b7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1365-3083.2001.00990.x","article-title":"Cytokine gene expression in healing and non-healing cases of cutaneous leishmaniasis in response to in vitro stimulation with recombinant gp63 using semi-quantitative RT\u2013PCR","volume":"54","author":"Habibi","year":"2001","journal-title":"Scand J Immunol"},{"key":"2022010405125948200_b8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2249.1994.tb06043.x","article-title":"Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis","volume":"96","author":"Kemp","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"2022010405125948200_b9","doi-asserted-by":"crossref","first-page":"6944","DOI":"10.1016\/j.vaccine.2006.05.016","article-title":"Surrogate markers of immunity to Leishmania major in leishmanin skin test negative individuals from an endemic area re-visited","volume":"24","author":"Nylen","year":"2006","journal-title":"Vaccine"},{"key":"2022010405125948200_b10","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"2022010405125948200_b11","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4049\/jimmunol.133.3.1250","article-title":"Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody","volume":"133","author":"Fox","year":"1984","journal-title":"J Immunol"},{"key":"2022010405125948200_b12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-3083.2001.00984.x","article-title":"CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes","volume":"54","author":"Gorrell","year":"2001","journal-title":"Scand J Immunol"},{"key":"2022010405125948200_b13","first-page":"685","article-title":"CD26 expression in leprosy and other granulomatous diseases correlates with the production of interferon-gamma","volume":"73","author":"Scheel-Toellner","year":"1995","journal-title":"Lab Invest"},{"key":"2022010405125948200_b14","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0091-6749(97)70248-3","article-title":"Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T (H1) subsets","volume":"100","author":"Willheim","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"2022010405125948200_b15","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.1073\/pnas.0501050102","article-title":"CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse","volume":"102","author":"Pacheco","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010405125948200_b16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2006.09.006","article-title":"CD4(+) memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis","volume":"181","author":"Krakauer","year":"2006","journal-title":"J Neuroimmunol"},{"key":"2022010405125948200_b17","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1006\/cyto.1999.0643","article-title":"Mechanisms of CD26\/dipeptidyl peptidase IV cytokine-dependent regulation on human activated lymphocytes","volume":"12","author":"Salgado","year":"2000","journal-title":"Cytokine"},{"key":"2022010405125948200_b18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000058395","article-title":"Serum levels of soluble CD26 and CD30 in patients on hemodialysis","volume":"91","author":"Nakao","year":"2002","journal-title":"Nephron"},{"key":"2022010405125948200_b19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000010328","article-title":"Changes in plasma soluble CD26 and CD30 during pregnancy: markers of Th1\/Th2 balance?","volume":"50","author":"Hoshimoto","year":"2000","journal-title":"Gynecol Obstet Invest"},{"key":"2022010405125948200_b20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2249.2006.03105.x","article-title":"Soluble CD26\/CD30 levels in visceral leishmaniasis: markers of disease activity","volume":"145","author":"Ajdary","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"2022010405125948200_b21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jinf.2006.12.005","article-title":"Soluble CD26 and CD30 levels in patients with anthroponotic cutaneous leishmaniasis","volume":"55","author":"Ajdary","year":"2007","journal-title":"J Infect"},{"key":"2022010405125948200_b22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1365-2249.2003.02299.x","article-title":"Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of bacille Calmette\u2013Gu\u00e9rin","volume":"134","author":"Mahmoodi","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"2022010405125948200_b23","first-page":"251","article-title":"T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy","volume":"9","author":"Da-Cruz","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"2022010405125948200_b24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-3024.2002.00488.x","article-title":"Endemically exposed asymptomatic individuals show no increase in the specific Leishmania (viannia) panamensis-Th1 immune response in comparison to patients with localized cutaneous leishmaniasis","volume":"24","author":"Trujillo","year":"2002","journal-title":"Parasite Immunol"},{"key":"2022010405125948200_b25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1365-3083.2000.00803.x","article-title":"Garlic induces a shift in cytokine pattern in Leishmania major-infected BALB\/c mice","volume":"52","author":"Ghazanfari","year":"2000","journal-title":"Scand J Immunol"},{"key":"2022010405125948200_b26","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1128\/IAI.66.6.2698-2704.1998","article-title":"Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity","volume":"66","author":"Maasho","year":"1998","journal-title":"Infect Immun"},{"key":"2022010405125948200_b27","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/j.1365-2133.1996.tb07941.x","article-title":"Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseases","volume":"134","author":"Novelli","year":"1996","journal-title":"Br J Dermatol"},{"key":"2022010405125948200_b28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2249.2001.01647.x","article-title":"An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy","volume":"126","author":"Keane","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"2022010405125948200_b29","first-page":"198","article-title":"Do the molecules CD26 and lymphocytes activation gene-3 differentiate between type 1 and 2 T cell response?","volume":"12","author":"Rogala","year":"2002","journal-title":"J Invest Allergol Clin Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2008.03666.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2008.03666.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/153\/1\/31\/42041208\/j.1365-2249.2008.03666.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/153\/1\/31\/42041208\/j.1365-2249.2008.03666.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T15:18:28Z","timestamp":1709306308000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/153\/1\/31\/6457505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,5]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,5,5]]},"published-print":{"date-parts":[[2008,6,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03666.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,7]]},"published":{"date-parts":[[2008,5,5]]}}}